about
Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosisA blast without power - cell death induced by the tuberculosis-necrotizing toxin fails to elicit adequate immune responses.Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patientsAn anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27High Interleukin 27 Production is Associated with Early Clinical Stage and Localized Disease in Patients with Melanoma.WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer.Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model.IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn.New insights into IL-12-mediated tumor suppression.Potential clinical application of interleukin-27 as an antitumor agent.Interleukin-27 signaling promotes immunity against endogenously arising murine tumors.The antitumor potential of Interleukin-27 in prostate cancer.Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected]..IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner.The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort studyPolymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signalingAssociations of IL-27 polymorphisms and serum IL-27p28 levels with osteosarcoma risk.Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant PathwayRegulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathwaysRole of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells.Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.Immune Regulation of Interleukin-27 in Malignant Pleural EffusionThe role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation.IL-27 induces the expression of IDO and PD-L1 in human cancer cells.The biology and therapeutic potential of interleukin 27.IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs.Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseAdvances in understanding the anti-inflammatory properties of IL-27.IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility GenesA pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes.Interleukins and cancer immunotherapy.
P2860
Q27014743-554A6534-FB74-485D-BE53-6B23D7A38259Q30799863-4C731820-7ADD-4245-B3C0-80646AE893FBQ33508227-9C0D6521-AC32-4144-A2C6-BDD244689FE6Q33773435-FC29ABB3-4D52-40D9-A50C-2D665B2D1581Q33798745-E9A923D0-D6BE-464D-9624-274A94B21F34Q33801032-6E7018BB-7A01-4DF0-98D8-524EC90C083FQ33895262-F91A38D6-4592-475C-96B0-9F7BE5E7F31EQ33907311-F2C56215-5066-47A1-88FB-5D9A7422B0FFQ33967201-8865BD32-CC24-4AE9-8DA6-B21717FAB07BQ33987288-AA1D4846-685E-419C-BD4D-6F23198FF452Q34064081-D67C75CA-26D1-4EE7-9270-212BF9736C61Q34436897-B671FF24-3773-4E09-BBB3-0F38B427986CQ34483131-4861828C-4E9B-4C59-A1F1-2AB532FC1CA5Q34647840-95BFCA20-942C-499B-9E5D-4C2509C0BFF3Q34786440-68E5856B-1D54-4107-A9E0-458E8139655DQ35018373-F774C7BC-9479-4271-8A41-02CB86BFBC2BQ35025256-FF73C3EF-856F-49E2-9566-C71C7E7946D3Q35166971-C80043D3-7094-411E-B2CF-A06988A31BEAQ35584162-52F3BC27-DE1B-40C3-A1C1-BF885F801E90Q35654119-42C5B4CA-DCA8-460A-9C48-05A461891B14Q35799014-FB155ED0-0687-4E43-A957-54255CF410E4Q35874404-BB155733-2765-431A-82A0-5BB2998CC67CQ36193602-A828994E-D4CA-4083-A930-79DF72A3083CQ36218965-A06F3C6D-5A76-43E5-AD62-B7E6D2F8F5BDQ36228914-761AEB45-EA64-47C7-B20E-63D73A2F07A7Q36333169-750C960F-C560-4519-800D-CA8BC28EB8F8Q36374816-11935D8A-909F-4C7F-91D8-B5F23FC1922FQ36477134-C5FAB2E0-1ABD-409E-A03A-CAA7A35FB39CQ36585494-B545057C-F0DC-46A0-91FC-DADA7EAAF816Q36685395-792ABC03-5E89-468D-A0CE-48C303AAFFB4Q36733744-451DF346-BA2F-4E69-9021-1D54A5490257Q36861764-F13DFE70-FF11-4C01-8108-63F2CD8EED10Q36928203-B6C7D3A4-53C7-4C7D-8152-7831C4F8558EQ37099883-73C047B9-3E52-4DE3-AD6A-55BA2CA2215AQ37124028-A32D1ECB-0BCD-4B0F-96C9-12FEA7071898Q37532498-66A4CDC7-7FC6-4DBF-BED7-8FC94D5F6650Q37687254-7BBF2594-8EE3-429E-A402-66708F80FFCBQ37734489-BF0E7BCE-24AE-4D31-93F3-6B6AB176584FQ37747078-D18B38A0-9749-44B0-9BBA-1798E05E1C12Q37773302-C37C8A9F-48D2-4FFE-BE75-906F78CAE350
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antiangiogenic and antitumor activities of IL-27.
@en
type
label
Antiangiogenic and antitumor activities of IL-27.
@en
prefLabel
Antiangiogenic and antitumor activities of IL-27.
@en
P2093
P1476
Antiangiogenic and antitumor activities of IL-27.
@en
P2093
Andrew D Luster
Junichiro Mizuguchi
Koji Fujita
Mariko Shimamura
Masayuki Asakawa
Motomu Shimizu
Motoshige Kudo
Takayuki Yoshimoto
Toshiyuki Owaki
Yasutaka Takeda
P304
P356
10.4049/JIMMUNOL.176.12.7317
P407
P577
2006-06-01T00:00:00Z